BMY vs RCMT · P/E 17, rev $24.46B vs P/E 14, rev $176.9M
Bristol-Myers Squibb Company (BMY) versus RCM Technologies Inc (RCMT) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
RCM Technologies Inc (RCMT) is a conglomerates company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RCMT revenue for 2026-07-04 was $176.9M. Net income was $8.7M. RCMT currently screens at market cap $181.8M and trailing P/E 14.1.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RCMT currently screens at market cap $181.8M and trailing P/E 14.1.
Not investment advice. Open the BMY and RCMT stock pages for the full models.
Not investment advice.